Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises on the sale of Ahlsell
Mandate

Vinge advises on the sale of Ahlsell

March 05, 2012

Vinge has advised the management of Ahlsell in connection with the sale of Ahlsell by Cinven, Golman Sachs and the company’s management to CVC for approximately SEK 16 billion and the management’s reinvestment in the new holding company for the Ahlsell Group. The new holding company is jointly owned with CVC. Signing took place on 28 February 2012. 

Vinge’s team consisted of partners Christina Kokko and Mattias Schömer and associates Paul Dali and Tora Hansjons.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026